Zollinger-Ellison syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
(6 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Zollinger-Ellison syndrome}} | {{Zollinger-Ellison syndrome}} | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{ARK}} {{MJK}} | ||
==Overview== | ==Overview== | ||
In mild cases if left untreated, patients with Zollinger-Ellison syndrome may further develop [[abdominal pain]], [[diarrhea]], [[heartburn]]. Common complications of Zollinger-Ellison syndrome include [[upper gastrointestinal bleeding]], [[anemia]], and [[duodenal ulcer perforation]]. Prognosis is generally good when treated and the 5 and 10-year survival rate of patients with Zollinger-Ellison syndrome is around 94% and 75%, respectively. In severe cases if left untreated, ZES results in refractory [[peptic ulcer disease]], severe [[gastroesophageal reflux disease]], [[diarrhea]], [[weight loss]], [[anemia]] and finally death, mainly due to the complications of the refractory [[peptic ulcer disease]]. | |||
==Natural History | ==Natural History, Complications, and Prognosis== | ||
==Complications== | === Natural History === | ||
*ZES is a condition wherein the ectopic secretion of [[gastrin]] by a [[gastrinoma]], primarily in the [[duodenum]] (60%-80%) or [[pancreas]] (10%-40%), results in the [[gastric acid]] hypersecretion. If left untreated, it results in refractory [[peptic ulcer disease]], severe [[gastroesophageal reflux disease]] ([[GERD]]), [[diarrhea]] and finally death, mainly due to complications of the refractory [[peptic ulcer disease]]. <ref name="pmid23112541">{{cite journal| author=Ito T, Cadiot G, Jensen RT| title=Diagnosis of Zollinger-Ellison syndrome: increasingly difficult. | journal=World J Gastroenterol | year= 2012 | volume= 18 | issue= 39 | pages= 5495-503 | pmid=23112541 | doi=10.3748/wjg.v18.i39.5495 | pmc=3482635 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23112541 }} </ref> | |||
*In mild cases if left untreated, patients may further develop [[abdominal pain]], [[diarrhea]], and [[heartburn]].<ref name="pmid11144036">{{cite journal| author=Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL et al.| title=Zollinger-Ellison syndrome. Clinical presentation in 261 patients. | journal=Medicine (Baltimore) | year= 2000 | volume= 79 | issue= 6 | pages= 379-411 | pmid=11144036 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11144036 }} </ref> | |||
*The symptoms usually develop in the third decade of life and when left untreated, the patient may develop symptoms of [[gastrinoma]], which may eventually lead to [[anemia]] and death.<ref>Riegert-Johnson D, Gleeson FC, Westra W, et al. Peutz-Jeghers Syndrome. 2008 Jul 18 [Updated 2008 Aug 9]. In: Riegert-Johnson DL, Boardman LA, Hefferon T, et al., editors. Cancer Syndromes [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2009-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1826/</ref> | |||
===Complications=== | |||
Common complications associated with Zollinger-Ellison syndrome include: | Common complications associated with Zollinger-Ellison syndrome include: | ||
*[[Upper gastrointestinal bleeding]] | *[[Upper gastrointestinal bleeding]] | ||
Line 19: | Line 21: | ||
*[[Weight loss]] | *[[Weight loss]] | ||
==Prognosis== | ===Prognosis=== | ||
The prognosis of Zollinger-Ellison syndrome is good | |||
* The prognosis of Zollinger-Ellison syndrome is generally good when treated. | |||
* The 5 and 10-year survival rates of patients with ZES is around 94% and 75%, respectively. | |||
* In most of the cases when left untreated, Zollinger-Ellison syndrome may result in [[weight loss]], [[anemia]], and death.<ref name="pmid7903006">{{cite journal| author=Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC| title=Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. | journal=Surgery | year= 1993 | volume= 114 | issue= 6 | pages= 1183-8 | pmid=7903006 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7903006 }} </ref> | |||
==References== | ==References== |
Latest revision as of 16:00, 19 September 2019
Zollinger-Ellison syndrome Microchapters |
Differentiating Zollinger-Ellison syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Zollinger-Ellison syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Zollinger-Ellison syndrome natural history, complications and prognosis |
FDA on Zollinger-Ellison syndrome natural history, complications and prognosis |
CDC on Zollinger-Ellison syndrome natural history, complications and prognosis |
Zollinger-Ellison syndrome natural history, complications and prognosis in the news |
Blogs on Zollinger-Ellison syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2] Mohamad Alkateb, MBBCh [3]
Overview
In mild cases if left untreated, patients with Zollinger-Ellison syndrome may further develop abdominal pain, diarrhea, heartburn. Common complications of Zollinger-Ellison syndrome include upper gastrointestinal bleeding, anemia, and duodenal ulcer perforation. Prognosis is generally good when treated and the 5 and 10-year survival rate of patients with Zollinger-Ellison syndrome is around 94% and 75%, respectively. In severe cases if left untreated, ZES results in refractory peptic ulcer disease, severe gastroesophageal reflux disease, diarrhea, weight loss, anemia and finally death, mainly due to the complications of the refractory peptic ulcer disease.
Natural History, Complications, and Prognosis
Natural History
- ZES is a condition wherein the ectopic secretion of gastrin by a gastrinoma, primarily in the duodenum (60%-80%) or pancreas (10%-40%), results in the gastric acid hypersecretion. If left untreated, it results in refractory peptic ulcer disease, severe gastroesophageal reflux disease (GERD), diarrhea and finally death, mainly due to complications of the refractory peptic ulcer disease. [1]
- In mild cases if left untreated, patients may further develop abdominal pain, diarrhea, and heartburn.[2]
- The symptoms usually develop in the third decade of life and when left untreated, the patient may develop symptoms of gastrinoma, which may eventually lead to anemia and death.[3]
Complications
Common complications associated with Zollinger-Ellison syndrome include:
Prognosis
- The prognosis of Zollinger-Ellison syndrome is generally good when treated.
- The 5 and 10-year survival rates of patients with ZES is around 94% and 75%, respectively.
- In most of the cases when left untreated, Zollinger-Ellison syndrome may result in weight loss, anemia, and death.[4]
References
- ↑ Ito T, Cadiot G, Jensen RT (2012). "Diagnosis of Zollinger-Ellison syndrome: increasingly difficult". World J Gastroenterol. 18 (39): 5495–503. doi:10.3748/wjg.v18.i39.5495. PMC 3482635. PMID 23112541.
- ↑ Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL; et al. (2000). "Zollinger-Ellison syndrome. Clinical presentation in 261 patients". Medicine (Baltimore). 79 (6): 379–411. PMID 11144036.
- ↑ Riegert-Johnson D, Gleeson FC, Westra W, et al. Peutz-Jeghers Syndrome. 2008 Jul 18 [Updated 2008 Aug 9]. In: Riegert-Johnson DL, Boardman LA, Hefferon T, et al., editors. Cancer Syndromes [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2009-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1826/
- ↑ Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC (1993). "Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia". Surgery. 114 (6): 1183–8. PMID 7903006.